Global HER2 Antibodies Market (2022-2027) by Type of Treatment, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global HER2 Antibodies Market (2022-2027) by Type of Treatment, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Introduction

The Global HER2 Antibodies Market is estimated to be USD 6.2 Bn in 2022 and is expected to reach USD 10.03 Bn by 2027, growing at a CAGR of 10.1%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global HER2 Antibodies Market is segmented based on Type of Treatment, and Geography.

  • By Type of Treatment, the market is classified into Trastuzumab, Lapatinib, Ado-trastuzumab emtansine, Pertuzumab, and Everolimus.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.
Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Novartis Ag, Bovie Medical Corp., Genentech Inc., Karl Storz, B. Braun Melsungen, AG KLS Martin, Abnova Corp., etc.

Countries Studied
  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global HER2 Antibodies Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

Infogence Global Research analyses the Global HER2 Antibodies Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report?
  • The report offers a comprehensive evaluation of the Global HER2 Antibodies Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence's Proprietary competitive positioning tool.
Report Highlights:
  • A complete analysis of the market, including parent industryImportant market dynamics and trendsMarket segmentationHistorical, current, and projected size of the market based on value and volumeMarket shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market


1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increase in Incidence of Breast Cancer
4.1.2 Rise in the Cost of Breast Cancer Treatment
4.2 Restraints
4.2.1 Dearth of the Skilled and Trained Professionals
4.3 Opportunities
4.3.1 Technological Advancements Such as Introduction of Hybrid Imaging Technique, Immunotherapies
4.3.2 Ongoing Focus on Development of Effective Diagnostic
4.4 Challenges
4.4.1 Ignorance towards of the Prediagnostic Symptoms
4.4.2 The Development of Intrinsic or Acquired Resistance to Targeted Therapy
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global HER2 Antibodies Market, By Type of Treatment
6.1 Introduction
6.2 Trastuzumab
6.3 Lapatinib
6.4 Ado-trastuzumab emtansine
6.5 Pertuzumab
6.6 Everolimus
7 Americas’ HER2 Antibodies Market
7.1 Introduction
7.2 Argentina
7.3 Brazil
7.4 Canada
7.5 Chile
7.6 Colombia
7.7 Mexico
7.8 Peru
7.9 United States
7.10 Rest of Americas
8 Europe’s HER2 Antibodies Market
8.1 Introduction
8.2 Austria
8.3 Belgium
8.4 Denmark
8.5 Finland
8.6 France
8.7 Germany
8.8 Italy
8.9 Netherlands
8.10 Norway
8.11 Poland
8.12 Russia
8.13 Spain
8.14 Sweden
8.15 Switzerland
8.16 United Kingdom
8.17 Rest of Europe
9 Middle East and Africa’s HER2 Antibodies Market
9.1 Introduction
9.2 Egypt
9.3 Israel
9.4 Qatar
9.5 Saudi Arabia
9.6 South Africa
9.7 United Arab Emirates
9.8 Rest of MEA
10 APAC’s HER2 Antibodies Market
10.1 Introduction
10.2 Australia
10.3 Bangladesh
10.4 China
10.5 India
10.6 Indonesia
10.7 Japan
10.8 Malaysia
10.9 Philippines
10.10 Singapore
10.11 South Korea
10.12 Sri Lanka
10.13 Thailand
10.14 Taiwan
10.15 Rest of Asia-Pacific
11 Competitive Landscape
11.1 IGR Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 Novartis Ag
12.2 Bovie Medical Corp.
12.3 Genentech Inc.
12.4 Karl Storz
12.5 B. Braun Melsungen
12.6 AG KLS Martin
12.7 Abnova Corp.
12.8 Pfizer, Inc.
12.9 InvivoGen
12.10 Biocon, Ltd.
12.11 Medtronic
12.12 Medical Technologies
12.13 Bio-Techne
12.14 Celltrion, Inc.
12.15 Maxer Endoscopy GmbH
12.16 Olympus Corp.
13 Appendix
13.1 Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings